ALXN-1920
- Generic Name
- ALXN-1920
Safety and Tolerability, Pharmacokinetic, and Pharmacodynamic Study of ALXN1920 in Healthy Participants
- First Posted Date
- 2023-03-02
- Last Posted Date
- 2024-11-27
- Lead Sponsor
- Alexion Pharmaceuticals, Inc.
- Target Recruit Count
- 48
- Registration Number
- NCT05751642
- Locations
- 🇳🇿
Research Site, Christchurch, New Zealand
🇳🇿Clinical Trial Site, Grafton, Auckland, New Zealand
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath